2024 Fall Conference | L3 - Emotional Intelligence in Action: Navigating Conflict in Difficult Times

Date Friday 10/25/24

Time 03:00 PM - 04:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Anthony Izzo, DO, FAAN, Carrie M. Hersh, DO, MSc, FAAN, Robin Stubblefield, MA, ACC

Topic(s) Leadership

Learning Objectives Leadership University sessions are open to all Fall Conference attendees and are designed to be inclusive of advanced practice providers, business administrators, trainees, and neurologists at all career stages. Participants should be able to recognize the difference between conflict management and conflict de-escalation; define emotional intelligence (EI) and the key skills that support it; gain insight and strategies for how to effectively regulate their own EI skills while fostering regulation in others, especially in times of conflict; and identify growth opportunities and action steps to further develop their EI regulation when leading both self and others. Leadership development is personal development, so please join us!

CME Available 1.50 CME credits

Core Competencies Interpersonal and Communication Skills, Professionalism, Quality Improvement

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator, Coordinator

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:00 PM - 04:30 PM PDT	Speaker	Emotional Intelligence in Action: Navigating Conflict in Difficult Times Anthony Izzo, DO, FAAN, Carrie M. Hersh, DO, MSc, FAAN, Robin Stubblefield, MA, ACC

Faculty Disclosures
Anthony Izzo, DO, FAAN	Dr. Izzo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals.
Carrie M. Hersh, DO, MSc, FAAN	Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech_GN41791. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb . Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Hersh has received research support from Biogen. The institution of Dr. Hersh has received research support from Novartis. The institution of Dr. Hersh has received research support from Genentech_GN41791. The institution of Dr. Hersh has received research support from PCORI. The institution of Dr. Hersh has received research support from Bristol Myers Squibb.
Robin Stubblefield, MA, ACC	Robin Stubblefield, MA, ACC has nothing to disclose.

��ɫ��

��ɫ��